thyroxine has been researched along with Carcinoma, Papillary, Follicular in 21 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Carcinoma, Papillary, Follicular: A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The development of hyponatremia during LT4 withdrawal and low-iodine diet in otherwise healthy patients with thyroid carcinoma is extremely rare." | 7.74 | Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. ( Clyde, PW; Hays, JH; Krook, LS; Schraml, FV; Shakir, MK, 2008) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 7.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "The development of hyponatremia during LT4 withdrawal and low-iodine diet in otherwise healthy patients with thyroid carcinoma is extremely rare." | 3.74 | Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. ( Clyde, PW; Hays, JH; Krook, LS; Schraml, FV; Shakir, MK, 2008) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 3.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "Differentiated thyroid carcinoma is the most common pediatric endocrine tumor, constituting 0." | 2.44 | Thyroid nodules and cancers in children. ( Josefson, J; Zimmerman, D, 2008) |
| "This is the second review article on thyroid cancer dealing with the common differentiated types that comprise 90% of thyroid cancers." | 2.43 | Thyroid cancer review 2: management of differentiated thyroid cancers. ( Coatesworth, AP; Nicolaides, A; Nix, P, 2005) |
| "More than 90% of primary thyroid cancers are differentiated papillary or follicular types." | 2.42 | Follow-up of differentiated thyroid carcinoma. ( Angellotti, G; Biondi, B; Klain, M; Lombardi, G; Pagano, L; Pasano, F; Pulcrano, M; Salvatore, M, 2004) |
| "Papillary and follicular thyroid cancer in childhood and adolescence is more advanced upon presentation than in adults, as evident from a higher frequency of extra-thyroidal spread." | 2.41 | Thyroid cancer in children and adolescents--consequences in later life. ( Wiersinga, WM, 2001) |
| "The prevalence of Hashimoto thyroiditis and NHLT in the 560 papillary thyroid cancer (PTC) patients was found to be 7." | 1.38 | Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. ( Hong, HP; Jung, SJ; Kang, T; Kim, DW; Kim, YW; Kwon, MJ; Park, YM; Rho, MH, 2012) |
| " After complete thyroidectomy and substitution with levothyroxine (l-T(4)), the preoperative, inadequately low T(4) and free T(4) remained, while increasing the l-T(4) dosage led to T(3) serum concentrations above the normal range." | 1.37 | Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy. ( Chiu-Ugalde, J; de Angelis, MH; Grüters, A; Klein, MO; Köhrle, J; Krude, H; Mossbrugger, I; Quintanilla-Martinez, L; Riebel, T; Rothe, K; Sapin, R; Schmid, KW; Schweizer, U; Sheu, SY; Wirth, EK, 2011) |
| "Insulin resistance is closely related to post-THW hypothyroidism in patients of DTC." | 1.35 | Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal. ( Chang, WD; Huang, SC; Lin, SY; Lin, YH; Sheu, WH; Song, YM; Wu, CC; Wu, VC, 2009) |
| "Optimal management of differentiated thyroid cancer in childhood is undetermined." | 1.33 | Importance of thyroglobulin levels for diagnosis and monitoring of follicular thyroid carcinoma in an adolescent with severe iodine deficiency. ( Adiyaman, P; Berberoğlu, M; Ergür, AT; Evliyaoğlu, O; Ocal, G; Sak, SD; Siklar, Z, 2006) |
| " If thyroglobulin remains undetectable during L-thyroxine treatment, an annual dosage is indicated and other exams are unwarranted." | 1.30 | [Papillary and follicular cancers of the thyroid]. ( Baudin, E; Schlumberger, M; Travagli, JP, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 15 (71.43) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shakir, MK | 1 |
| Krook, LS | 1 |
| Schraml, FV | 1 |
| Hays, JH | 1 |
| Clyde, PW | 1 |
| Josefson, J | 1 |
| Zimmerman, D | 1 |
| Huang, SC | 1 |
| Wu, VC | 1 |
| Lin, SY | 1 |
| Sheu, WH | 1 |
| Song, YM | 1 |
| Lin, YH | 1 |
| Wu, CC | 1 |
| Chang, WD | 1 |
| Emmanouilidis, N | 1 |
| Müller, JA | 1 |
| Jäger, MD | 1 |
| Kaaden, S | 1 |
| Helfritz, FA | 1 |
| Güner, Z | 1 |
| Kespohl, H | 1 |
| Knitsch, W | 1 |
| Knapp, WH | 1 |
| Klempnauer, J | 1 |
| Scheumann, GF | 1 |
| Brassard, M | 1 |
| Borget, I | 1 |
| Edet-Sanson, A | 1 |
| Giraudet, AL | 1 |
| Mundler, O | 1 |
| Toubeau, M | 1 |
| Bonichon, F | 1 |
| Borson-Chazot, F | 1 |
| Leenhardt, L | 1 |
| Schvartz, C | 1 |
| Dejax, C | 1 |
| Brenot-Rossi, I | 1 |
| Toubert, ME | 1 |
| Torlontano, M | 1 |
| Benhamou, E | 1 |
| Schlumberger, M | 3 |
| Wirth, EK | 1 |
| Sheu, SY | 1 |
| Chiu-Ugalde, J | 1 |
| Sapin, R | 1 |
| Klein, MO | 1 |
| Mossbrugger, I | 1 |
| Quintanilla-Martinez, L | 1 |
| de Angelis, MH | 1 |
| Krude, H | 1 |
| Riebel, T | 1 |
| Rothe, K | 1 |
| Köhrle, J | 1 |
| Schmid, KW | 1 |
| Schweizer, U | 1 |
| Grüters, A | 1 |
| Guerrissi, JO | 1 |
| Rho, MH | 1 |
| Kim, DW | 1 |
| Hong, HP | 1 |
| Park, YM | 1 |
| Kwon, MJ | 1 |
| Jung, SJ | 1 |
| Kim, YW | 1 |
| Kang, T | 1 |
| Botella-Carretero, JI | 1 |
| Gómez-Bueno, M | 1 |
| Barrios, V | 1 |
| Caballero, C | 1 |
| García-Robles, R | 1 |
| Sancho, J | 1 |
| Escobar-Morreale, HF | 1 |
| Pagano, L | 1 |
| Klain, M | 1 |
| Pulcrano, M | 1 |
| Angellotti, G | 1 |
| Pasano, F | 1 |
| Salvatore, M | 1 |
| Lombardi, G | 1 |
| Biondi, B | 1 |
| Nix, P | 1 |
| Nicolaides, A | 1 |
| Coatesworth, AP | 1 |
| Chrisoulidou, A | 1 |
| Pazaitou-Panayiotou, K | 1 |
| Kaprara, A | 1 |
| Platoyiannis, D | 1 |
| Lafaras, C | 1 |
| Boudina, M | 1 |
| Georgiou, E | 1 |
| Drimonitis, A | 1 |
| Bischiniotis, T | 1 |
| Vainas, I | 1 |
| Siklar, Z | 1 |
| Ocal, G | 1 |
| Berberoğlu, M | 1 |
| Adiyaman, P | 1 |
| Ergür, AT | 1 |
| Evliyaoğlu, O | 1 |
| Sak, SD | 1 |
| Dulgeroff, AJ | 1 |
| Hershman, JM | 1 |
| Baudin, E | 1 |
| Travagli, JP | 1 |
| Jarzab, B | 1 |
| Handkiewicz Junak, D | 1 |
| Włoch, J | 1 |
| Kalemba, B | 1 |
| Roskosz, J | 1 |
| Kukulska, A | 1 |
| Puch, Z | 1 |
| Taniyama, M | 1 |
| Ishikawa, N | 1 |
| Momotani, N | 1 |
| Ito, K | 1 |
| Ban, Y | 1 |
| de Keizer, B | 1 |
| Koppeschaar, HP | 1 |
| Zelissen, PM | 1 |
| Lips, CJ | 1 |
| van Rijk, PP | 1 |
| van Dijk, A | 1 |
| de Klerk, JM | 1 |
| Wiersinga, WM | 1 |
| Jones, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma[NCT01813136] | Phase 2 | 168 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for thyroxine and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Thyroid nodules and cancers in children.
Topics: Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Child; Disease Susceptibility; Follow-Up Stu | 2008 |
Follow-up of differentiated thyroid carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Papillary, Follicular; Humans; Iodine Radioisotopes; Sensitivity and S | 2004 |
Thyroid cancer review 2: management of differentiated thyroid cancers.
Topics: Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Humans; Hypothyroidism; Neck; Thyroid Neopla | 2005 |
[Papillary and follicular thyroid carcinoma].
Topics: Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Humans; Neoplasm Metastasis; Prognosis; Thyr | 2007 |
Medical therapy for differentiated thyroid carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary, | 1994 |
Thyroid cancer in children and adolescents--consequences in later life.
Topics: Adolescent; Adult; Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Child, Preschool; Humans; | 2001 |
2 trials available for thyroxine and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH.
Topics: Adult; Carcinoma, Papillary, Follicular; Cohort Studies; Combined Modality Therapy; Female; Humans; | 2009 |
Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin.
Topics: Adult; Aged; Carcinoma, Papillary, Follicular; Female; Follow-Up Studies; Humans; Iodine Radioisotop | 2001 |
13 other studies available for thyroxine and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Aldosterone; Carcinoma, Papillary, Follicular; Diet; Female; Humans; Hypona | 2008 |
Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Topics: Adult; Body Mass Index; Carcinoma, Papillary, Follicular; Cholesterol; Female; Homeostasis; Humans; | 2009 |
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Carcinoma, Papillary, Follicular; Cohort | 2011 |
Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy.
Topics: Animals; Blotting, Western; Carcinoma, Papillary, Follicular; Child; Electrophoresis, Polyacrylamide | 2011 |
Follicular variant of papillary carcinoma in submandibular ectopic thyroid with no orthotopic thyroid gland.
Topics: Adult; Carcinoma, Papillary, Follicular; Cell Transformation, Neoplastic; Choristoma; Diagnosis, Dif | 2012 |
Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results.
Topics: Adult; Aged; Analysis of Variance; Antibodies; Carcinoma, Papillary, Follicular; Female; Hashimoto D | 2012 |
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Topics: Adult; Blood Pressure; Carcinoma, Papillary, Follicular; Cardiovascular Diseases; Cell Differentiati | 2004 |
Effects of thyroxine withdrawal in biochemical parameters and cardiac function and structure in patients with differentiated thyroid cancer.
Topics: Biomarkers; Carcinoma, Papillary, Follicular; Cardiovascular Diseases; Case-Control Studies; Creatin | 2006 |
Importance of thyroglobulin levels for diagnosis and monitoring of follicular thyroid carcinoma in an adolescent with severe iodine deficiency.
Topics: Adolescent; Antithyroid Agents; Biopsy; Carcinoma, Papillary, Follicular; Female; Goiter, Nodular; H | 2006 |
[Papillary and follicular cancers of the thyroid].
Topics: Carcinoma, Papillary, Follicular; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymph Node Excisi | 1998 |
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.
Topics: Adolescent; Carcinoma, Papillary, Follicular; Child; Disease-Free Survival; Female; Humans; Iodine R | 2000 |
Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
Topics: Amino Acids; Biomarkers; Carcinoma, Papillary, Follicular; Female; Goiter, Nodular; Humans; Middle A | 2001 |
Management of papillary and follicular thyroid cancer.
Topics: Carcinoma, Papillary, Follicular; Humans; Iodine Radioisotopes; Risk Factors; Thyroglobulin; Thyroid | 2002 |